[11C]UCB-J is a PET radioligand that binds to the presynaptic vesicle glycoprotein 2A. Therefore, [11C]UCB-J PET may serve as an in vivo marker of synaptic integrity. The main objective of this study was to evaluate the quantitative accuracy and the 28-day test-retest repeatability (TRT) of various parametric quantitative methods for dynamic [11C]UCB-J studies in Alzheimer's disease (AD) patients and healthy controls (HC). Eight HCs and seven AD patients underwent two 60-min dynamic [11C]UCB-J PET scans with arterial sampling over a 28-day interval. Several plasma-input based and reference-region based parametric methods were used to generate parametric images using metabolite corrected plasma activity as input function or white matter semi...
Objectives: Characteristic neuropathologic changes in Alzheimer disease (AD) are amyloid-beta depos...
Tau accumulation in the brain is a pathological hallmark of Alzheimer’s disease (AD) and other tauop...
Aim PET imaging with [18F]PM-PBB3 (a.k.a.[18F]APN-1607*) has demonstrated the capability of this rad...
[11C]UCB-J is a PET radioligand that binds to the presynaptic vesicle glycoprotein 2A. Therefore, [1...
[11C]UCB-J is a novel radioligand that binds to synaptic vesicle glycoprotein 2A (SV2A). The main ob...
[C-11]UCB-J is a novel radioligand that binds to synaptic vesicle glycoprotein 2A (SV2A). The main o...
Accumulation of amyloid beta (Aβ) is one of the pathological hallmarks of Alzheimer’s disease (AD), ...
Accumulation of amyloid beta (A beta) is one of the pathological hallmarks of Alzheimer's disease (A...
The aim of this study was to investigate the test–retest (TRT) repeatability of various parametric q...
PURPOSE: In order to maximise the utility of [(11)C]-PBR28 for use in longitudinal studies and clini...
Purpose: In order to maximise the utility of [11C]-PBR28 for use in longitudinal studies and clinica...
Activated microglia can be visualised using (R)-[11C]PK11195 (1-[2-chlorophenyl]-N-methyl-N-[1-methy...
Background P-glycoprotein [Pgp] dysfunction may be involved in neurodegenerative diseases, such as A...
Aim PET imaging with [18F]PM-PBB3 ([18F]APN-1607) has demonstrated the capability of this radioligan...
OBJECTIVES: The amyloid imaging PET tracer [(18)F]flutemetamol was recently approved by regulatory a...
Objectives: Characteristic neuropathologic changes in Alzheimer disease (AD) are amyloid-beta depos...
Tau accumulation in the brain is a pathological hallmark of Alzheimer’s disease (AD) and other tauop...
Aim PET imaging with [18F]PM-PBB3 (a.k.a.[18F]APN-1607*) has demonstrated the capability of this rad...
[11C]UCB-J is a PET radioligand that binds to the presynaptic vesicle glycoprotein 2A. Therefore, [1...
[11C]UCB-J is a novel radioligand that binds to synaptic vesicle glycoprotein 2A (SV2A). The main ob...
[C-11]UCB-J is a novel radioligand that binds to synaptic vesicle glycoprotein 2A (SV2A). The main o...
Accumulation of amyloid beta (Aβ) is one of the pathological hallmarks of Alzheimer’s disease (AD), ...
Accumulation of amyloid beta (A beta) is one of the pathological hallmarks of Alzheimer's disease (A...
The aim of this study was to investigate the test–retest (TRT) repeatability of various parametric q...
PURPOSE: In order to maximise the utility of [(11)C]-PBR28 for use in longitudinal studies and clini...
Purpose: In order to maximise the utility of [11C]-PBR28 for use in longitudinal studies and clinica...
Activated microglia can be visualised using (R)-[11C]PK11195 (1-[2-chlorophenyl]-N-methyl-N-[1-methy...
Background P-glycoprotein [Pgp] dysfunction may be involved in neurodegenerative diseases, such as A...
Aim PET imaging with [18F]PM-PBB3 ([18F]APN-1607) has demonstrated the capability of this radioligan...
OBJECTIVES: The amyloid imaging PET tracer [(18)F]flutemetamol was recently approved by regulatory a...
Objectives: Characteristic neuropathologic changes in Alzheimer disease (AD) are amyloid-beta depos...
Tau accumulation in the brain is a pathological hallmark of Alzheimer’s disease (AD) and other tauop...
Aim PET imaging with [18F]PM-PBB3 (a.k.a.[18F]APN-1607*) has demonstrated the capability of this rad...